Theranos to close its labs and blood-testing centers and lose 340 staff

Embattled founder Elizabeth Holmes once boasted her $9bn business would change the world, but Theranos’s decline is now a cautionary tale

Elizabeth Holmes, the embattled founder and chief executive of Theranos, said late on Wednesday that the company will close its clinical labs and Walgreens testing centers in the US.

In an open letter posted on the company’s website, Holmes praised the consumer-facing business that she once boasted would change the world with its inexpensive pinprick blood test, and was once the toast of Silicon Valley.

In magazine interviews, TV appearances and keynote speeches she gave around the world, Holmes said the innovation would empower consumers by giving them the ability to bypass the gatekeepers – their doctors – to get important information about the health of their own bodies.

Numerous investors and consumers fell for her story, and at one point the company was valued at $9bn, making Holmes the youngest self-made female billionaire ever. But as the company grew, so did questions about its technology. In a series of skeptical reports starting in October 2015, the Wall Street Journal recounted how even Theranos’s own employees questioned the accuracy of the results of its testing and revealed that government regulators had been looking into the matter.

The company aggressively defended itself against the accusations but in summer 2016 began to acknowledge some major defeats.

In June, Walgreens said it had terminated its partnership with the blood-testing startup effective immediately.

In July, the Centers for Medicare & Medicaid Services imposed harsh sanctions against Theranos, levying a fine, revoking its certification to operate labs and banning Holmes from owning, operating or directing a blood-testing lab for at least two years.

The company also faces federal criminal and civil investigations into whether it misled investors. The company denies any wrongdoing.

Wednesday’s announcement by Theranos essentially shuts down the consumer-facing operations that were at the heart of the vision Holmes promoted.

The move will affect about 340 employees in Arizona, California and Pennsylvania. “We are profoundly grateful to these team members, many of whom have devoted years to Theranos and our mission, for their commitment to our company and our guests,” Holmes wrote.

The company will now focus its “undivided attention” on its new Theranos miniLab platform, which she described as a product that would be “miniaturized, automated laboratories capable of small-volume sample testing, with an emphasis on vulnerable patient populations, including oncology, pediatrics, and intensive care”.

Theranos’s journey is a cautionary tale for the investors and reporters who showered praise on the company with little scrutiny. The firm raised more than $720m in funding before questions were raised over its core intellectual property.

What kind of due diligence did venture capitalists conduct before handing over millions of dollars? A number of scientists expressed doubts about Theranos early on, while more cautious investors tend to avoid medical companies unless their core product has been rigorously tested and peer-reviewed.

Theranos is not the only Silicon Valley company to have doubt cast upon its core science. Former employees said that San Francisco-based vegan food company Hampton Creek, which markets itself as a technology company, exaggerated how advanced its technology was. More recently Bloomberg reported that the company had been engaged in an alleged undercover buyback campaign, where members of staff were tasked with buying up jars of Hampton Creek’s eggless mayonnaise product Just Mayo. The US justice department has since opened up a criminal investigation into whether the company committed fraud.


Agencies, and Olivia Solon in San Francisco

The GuardianTramp

Related Content

Article image
Theranos could be banned from running labs for two years, regulators warn
Blood-testing startup accused of not resolving issues found during inspection earlier this year that created ‘immediate jeopardy to patient health and safety’

Jemima Kiss in San Francisco

13, Apr, 2016 @7:46 PM

Article image
Theranos blood-testing lab poses 'immediate' risk – US government
‘Immediate corrective action’ is needed at the blood-testing firm’s California lab, a health agency has told the Silicon Valley unicorn

Nicky Woolf in San Francisco

27, Jan, 2016 @11:16 PM

Article image
Elizabeth Holmes to be sentenced this week as Theranos saga nears conclusion
The blood testing company’s founder could serve up to 20 years in prison after she was convicted in January on four counts of fraud

Kari Paul in San Francisco

14, Nov, 2022 @11:00 AM

Article image
From a Jeff Bezos romcom to an Elon Musk thriller, our wish list of tech movies
With Jennifer Lawrence signed on to star in a film about Theranos, we made a list of the Silicon Valley hotshots we want to see played on the big screen

Nellie Bowles and Julia Carrie Wong in San Francisco

11, Jun, 2016 @12:00 PM

Article image
Silicon Valley's biotech firms: 'Theranos gave us a black eye'
Despite signs of crisis among science startups, many still think that biotech will create companies so powerful that they will ‘win’ the 21st century

Nellie Bowles in San Francisco

18, Feb, 2016 @6:00 PM

Article image
Theranos and its founder Elizabeth Holmes charged with 'massive fraud'
Federal agency calls disgraced firm, which allegedly deceived investors of $700m, ‘an important lesson for Silicon Valley’

Julia Carrie Wong in San Francisco

14, Mar, 2018 @6:48 PM

Article image
Theranos founder Elizabeth Holmes charged with criminal fraud
Ramesh Balwani, former president of blood-testing startup, also charged and
pair appear in federal court hours after Holmes quits as CEO

Olivia Solon in San Francisco

15, Jun, 2018 @10:13 PM

Article image
Elder care on-demand: why tech is setting its sights on your parents
Conventional wisdom says apps aren’t for old people. But that may change as tech startups take on a sizable need: caring for elderly relatives

Moira Weigel

27, Jul, 2016 @10:00 AM

Article image
Jennifer Lawrence to play Elizabeth Holmes in movie about Theranos
Lawrence will portray the founder of the embattled biotech firm that was once valued at $9bn before journalists demolished many of the company’s claims

Nicky Woolf in San Francisco

09, Jun, 2016 @9:55 PM

Article image
Disgraced Theranos founder Elizabeth Holmes' trial could be delayed by pregnancy
Holmes is on trial for allegedly defrauding investors, doctors and patients while at the helm of blood-testing startup

Kari Paul and agencies

13, Mar, 2021 @2:13 AM